Cigna resumes mega merger talks with rival health insurer Humana, Bloomberg News reports
Adds background throughout, updates shares in paragraph 3
Oct 18 (Reuters) -U.S. health insurer Cigna Group CI.N has revived efforts to merge with smaller rival Humana HUM.N after abandoning the pursuit late last year, Bloomberg News reported on Friday, citing people familiar with the matter.
The companies have held informal, early discussions recently about a potential deal, the report said.
Shares of Humana, which has a market capitalization of about $32 billion, were up about 6% in after-hours trading on Friday, while those of Cigna were down about 5%. Cigna was valued at about $94 billion, according to data compiled by LSEG.
Cigna and Humana declined to comment.
Last year, Reuters reported that Cigna ended its attempt to negotiate an acquisition of Humana after the pair failed to agree on a price and announced a $10 billion worth of shares buyback.
No decision has been made and Cigna or Humana could opt to push any deal past the new year or decide against pursuing one altogether, the Bloomberg report said.
Cigna, which primarily deals with employer-sponsored healthcare plans, is in the process of selling its Medicare Advantage (MA) business that manages government-backed health insurance for people aged 65 and older.
It struck a $3.3 billion deal with insurer Health Care Service Corp earlier this year to sell its MA business.
Humana has lost nearly 40% of its value this year as it faces multiple challenges, including declining enrollments in its top-rated Medicare plans, elevated costs due to higher demand for medical care and lower-than-expected reimbursement rates from the government.
By the time the deal talks ended, sources had told Reuters that there was still a possibility of a tie-up in the future.
A fierce antitrust scrutiny was also looming at the time due to potential consolidation in the U.S. health insurance sector.
Reporting by Mariam Sunny in Bengaluru; Editing by Alan Barona
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
